135 related articles for article (PubMed ID: 33871409)
21. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.
Gantt S; Kakuru A; Wald A; Walusansa V; Corey L; Casper C; Orem J
Pediatr Blood Cancer; 2010 May; 54(5):670-4. PubMed ID: 20205254
[TBL] [Abstract][Full Text] [Related]
22. Predictive clinical factors in the diagnosis of gastrointestinal Kaposi's sarcoma and its endoscopic severity.
Nagata N; Shimbo T; Yazaki H; Asayama N; Akiyama J; Teruya K; Igari T; Ohmagari N; Oka S; Uemura N
PLoS One; 2012; 7(11):e46967. PubMed ID: 23226197
[TBL] [Abstract][Full Text] [Related]
23. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.
Bower M; Dalla Pria A; Coyle C; Andrews E; Tittle V; Dhoot S; Nelson M
J Clin Oncol; 2014 Feb; 32(5):409-14. PubMed ID: 24378415
[TBL] [Abstract][Full Text] [Related]
24. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
Leitch H; Trudeau M; Routy JP
HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
Ziegler JL; Katongole-Mbidde E
Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi.
Gopal S; Liomba NG; Montgomery ND; Moses A; Kaimila B; Nyasosela R; Chikasema M; Dhungel BM; Kampani C; Sanders MK; Krysiak R; Dittmer DP; Fedoriw Y
J Int AIDS Soc; 2015; 18(1):20122. PubMed ID: 26242311
[TBL] [Abstract][Full Text] [Related]
27. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
[TBL] [Abstract][Full Text] [Related]
28. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.
El-Mallawany NK; Kamiyango W; Slone JS; Villiera J; Kovarik CL; Cox CM; Dittmer DP; Ahmed S; Schutze GE; Scheurer ME; Kazembe PN; Mehta PS
PLoS One; 2016; 11(4):e0153335. PubMed ID: 27082863
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Kaposi sarcoma in children with HIV-1 infection.
Anglemyer A; Agrawal AK; Rutherford GW
Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
[TBL] [Abstract][Full Text] [Related]
31. Association Between Immunoglobulin E Levels and Kaposi Sarcoma in African Adults With Human Immunodeficiency Virus Infection.
Byakwaga H; Barbachano-Guerrero A; Wang D; McAllister S; Naphri K; Laker-Oketta M; Muzoora C; Hunt PW; Martin J; King CA
J Infect Dis; 2021 Jan; 223(1):101-108. PubMed ID: 32561934
[TBL] [Abstract][Full Text] [Related]
32. Fatal pulmonary Kaposi sarcoma in an HIV seronegative AIDS patient.
Zhang H; Wang HL; Zhong DR; Liu Y; Li NN; Zhang W; Xiao Y; Li TS
Clin Respir J; 2017 Nov; 11(6):1040-1044. PubMed ID: 26861193
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana.
Cox CM; El-Mallawany NK; Kabue M; Kovarik C; Schutze GE; Kazembe PN; Mehta PS
Pediatr Blood Cancer; 2013 Aug; 60(8):1274-80. PubMed ID: 23487320
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.
Uldrick TS; Wyvill KM; Kumar P; O'Mahony D; Bernstein W; Aleman K; Polizzotto MN; Steinberg SM; Pittaluga S; Marshall V; Whitby D; Little RF; Yarchoan R
J Clin Oncol; 2012 May; 30(13):1476-83. PubMed ID: 22430271
[TBL] [Abstract][Full Text] [Related]
36. Severe Kaposi Sarcoma in an Urban Public Hospital.
Kasturia SE; Gunthel C; Zeng C; Nguyen ML
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):583-589. PubMed ID: 28019110
[TBL] [Abstract][Full Text] [Related]
37. Establishing a multidisciplinary AIDS-associated Kaposi's sarcoma clinic: Patient characteristics, management and outcomes.
Burger H; Ismail Z; Taljaard JJ
S Afr Med J; 2018 Nov; 108(12):1059-1065. PubMed ID: 30606293
[TBL] [Abstract][Full Text] [Related]
38. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.
Mosam A; Shaik F; Uldrick TS; Esterhuizen T; Friedland GH; Scadden DT; Aboobaker J; Coovadia HM
J Acquir Immune Defic Syndr; 2012 Jun; 60(2):150-7. PubMed ID: 22395672
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
40. Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda.
Coghill AE; Schenk JM; Mahkoul Z; Orem J; Phipps W; Casper C
AIDS; 2018 Feb; 32(4):505-512. PubMed ID: 29381560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]